RecruitingNCT04551378

The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors

Impacts of Coronavirus Disease 2019 (COVID-19) Pandemic on Adolescent and Young Adult (AYA) Cancer Patients and Survivors

Sponsor

M.D. Anderson Cancer Center

Enrollment

600 participants

Start Date

Jul 13, 2020

Study Type

OBSERVATIONAL

Conditions

Malignant Solid Neoplasm Hematopoietic and Lymphoid Cell Neoplasm COVID-19 Infection

Summary

The study investigates how the COVID-19 pandemic has impacted the psychological, financial, physical, and social well-being of adolescent and young adult (AYA) cancer patients and survivors. AYA cancer survivors have inferior long-term survival compared to the general population, and the negative impact of the global COVID-19 pandemic may be even higher in this vulnerable group. The information gained from this study may provide an opportunity to determine the self-reported COVID-19 specific psychological distress in AYA cancer survivors, and may lead to the development of a targeted intervention to improve physical and psychosocial health for AYA cancer patients and survivors.

Eligibility

Min Age: 18 YearsMax Age: 39 Years

Plain Language Summary

Simplified for easier understanding

This study looks at how the COVID-19 pandemic affected the mental health and well-being of young adults who were diagnosed with cancer between the ages of 15 and 39. Participants are asked to complete questionnaires about their experiences during the pandemic. **You may be eligible if...** - You were first diagnosed with cancer between ages 15 and 39 - You received cancer treatment at MD Anderson Cancer Center - You are currently alive at the time you are contacted **You may NOT be eligible if...** - You are unable to complete questionnaires in English - You only visited MD Anderson for a second opinion or a non-treatment visit Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.